title: Normal glucose tolerance and gestational diabetes mellitus: what is in between?
abstract: OBJECTIVE
  The aim of this article was to define the metabolic phenotype of pregnant women with one abnormal value (OAV) during an oral glucose tolerance test (OGTT) and to test whether OAV could be considered metabolically comparable to gestational diabetes mellitus (GDM) or a specific entity between GDM and normal pregnancy.
  
  
  METHODS
  After 100-g 3-h OGTTs, 4,053 pregnant women were classified as having GDM, OAV, or normal glucose tolerance (NGT). Those with OAV were subdivided into three subgroups: fasting hyperglycemia (one abnormal value at fasting during an OGTT), 1-h hyperglycemia (one abnormal value at 1 h during an OGTT [1h-OAV]), or 2- or 3-h hyperglycemia (one abnormal value at 2 or 3 h during an OGTT). As derived from the OGTT, we measured insulin sensitivity (insulin sensitivity index [ISI] Matsuda) and insulin secretion (homeostasis model assessment for the estimation of beta-cell secretion [HOMA-B], first- and second-phase insulin secretion). The product of the first-phase index and the ISI was calculated to obtain the insulin secretion-sensitivity index (ISSI).
  
  
  RESULTS
  GDM was diagnosed in 17.9% and OAV in 18.7% of pregnant women; women with GDM and OAV were older and had higher BMI and serum triglyceride levels than those with NGT (all P < 0.05). Women with NGT had the highest ISI followed by those with OAV (-21.7%) and GDM (-32.1%). HOMA-B results were comparable with those for OAV and GDM but significantly (P < 0.01) lower than those for NGT; first- and second-phase insulin secretion appeared progressively reduced from that in women with NGT to that in women with OAV and GDM (P < 0.01). ISSI was higher in women with NGT than in women with either OAV (-34%) or GDM (-51.7%) (P < 0.001). Among OAV subgroups, the 1h-OAV subgroup showed the lowest ISSI (P < 0.05).
  
  
  CONCLUSIONS
  OAV and GDM are clinically indistinguishable, and both groups are different from women with NGT. Women with GDM and OAV showed impaired insulin secretion and insulin sensitivity, although these defects are more pronounced in women with GDM. Compared with other OAV subgroups, 1h-OAV could be considered a more severe condition.
authors.affiliation: Department of Endocrinology and Metabolism, Section of Diabetes and Metabolic Diseases, University of Pisa, 56126 Pisa, Italy. dicianni@immr.med.unipi.it
authors.forename: Graziano
authors.initials: G
authors.lastname: Di Cianni
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Seghieri
authors.forename: Cristina
authors.initials: C
authors.lastname: Lencioni
authors.forename: Ilaria
authors.initials: I
authors.lastname: Cuccuru
authors.forename: Roberto
authors.initials: R
authors.lastname: Anichini
authors.forename: Alessandra
authors.initials: A
authors.lastname: De Bellis
authors.forename: Alessandra
authors.initials: A
authors.lastname: Ghio
authors.forename: Federica
authors.initials: F
authors.lastname: Tesi
authors.forename: Laura
authors.initials: L
authors.lastname: Volpe
authors.forename: Stefano
authors.initials: S
authors.lastname: Del Prato
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000032:analysis*; D016640:Diabetes, Gestational / Q000097:blood / Q000175:diagnosis*; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D011247:Pregnancy
chemical_list: D001786:Blood Glucose